| pubmed-article:16128627 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C0003232 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C0025344 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C0521009 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C1701940 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C0282654 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C2347804 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C1561960 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C1880496 | lld:lifeskim |
| pubmed-article:16128627 | lifeskim:mentions | umls-concept:C1948053 | lld:lifeskim |
| pubmed-article:16128627 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16128627 | pubmed:dateCreated | 2005-8-30 | lld:pubmed |
| pubmed-article:16128627 | pubmed:abstractText | Evaluation of causative pathogens is vital for optimizing empiric antibiotic therapy of ventilator-associated pneumonia (VAP). Based on previous data (Ann Surg 1998;227:743-755), empiric antibiotics for our VAP clinical pathway were modified to target early and late occurring pathogens (ampicillin/sulbactam during the first week of hospitalization; cefepime plus vancomycin afterwards). The objectives of this study were to compare organisms causing VAP over a three-year period to previous data, and to determine the adequacy of the empiric antibiotic regimens. | lld:pubmed |
| pubmed-article:16128627 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16128627 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16128627 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16128627 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16128627 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16128627 | pubmed:issn | 1096-2964 | lld:pubmed |
| pubmed-article:16128627 | pubmed:author | pubmed-author:FabianTimothy... | lld:pubmed |
| pubmed-article:16128627 | pubmed:author | pubmed-author:WoodG... | lld:pubmed |
| pubmed-article:16128627 | pubmed:author | pubmed-author:HanesScott... | lld:pubmed |
| pubmed-article:16128627 | pubmed:author | pubmed-author:CroceMartin... | lld:pubmed |
| pubmed-article:16128627 | pubmed:author | pubmed-author:BoucherBradle... | lld:pubmed |
| pubmed-article:16128627 | pubmed:author | pubmed-author:MuellerEric... | lld:pubmed |
| pubmed-article:16128627 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16128627 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:16128627 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16128627 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16128627 | pubmed:pagination | 203-13 | lld:pubmed |
| pubmed-article:16128627 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:meshHeading | pubmed-meshheading:16128627... | lld:pubmed |
| pubmed-article:16128627 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16128627 | pubmed:articleTitle | Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period. | lld:pubmed |
| pubmed-article:16128627 | pubmed:affiliation | Department of Pharmacy, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA. cwood@utmem.edu | lld:pubmed |
| pubmed-article:16128627 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16128627 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16128627 | lld:pubmed |
